Therefore, increasing the concentration of serum albumin to decrease the unconjugated bilirubin concentrations in the circulation could be a strategy for confronting the bilirubin-induced neurotoxicity and AD-like injuries. The gene discussed is ALB; the disease is Alzheimer disease.